QTI

QT IMAGING HOLDINGS, INC.

Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001844505 Healthcare & Medical Devices

$2.28 −0.02 (−0.87%)

Oct 27 4:00 PM ET · prev $2.30

Market cap

$32.9M

Nano cap

Consensus

Buy

83% Buy or better · 6 analysts

Median target

🔒 Subscribers only

Next earnings

Nov 9

in 13 days

1 year

−67.8%

from $7.07 · Oct 28

30 days

−6.9%

from $2.45

52-week range

$2.25–7.59

−70% from high · low Oct 23

Avg volume 20D

33.9K

Oct 9 spike 179.0K

Short interest

🔒 Subscribers only

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

Filing reports

analyzed by SecBot

SecBot read BULLISH 2 reports · 90 days

Balance 0 bearish · 1 bullish · 1 neutral oldest → newest, height = score

Avg score

·High conf. 2/2 ·Next Earnings date, Nov 9, 2026

Strongest BULLISH QT Imaging issued a mid-year 2026 letter to shareholders highlighting strong H1 2026 revenue of $14.0M…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Feb 25 QT Imaging Holdings disclosed strong Q4 2025 financial results and 2…
R Aug 18 QT Imaging issued a mid-year 2026 letter to shareholders highlightin…
A Oct 5 Craig-Hallum initiates
A Oct 23 D. Boral Capital initiates

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsBULLISH

Q2 2026: 4 added (0 new), 0 trimmed or exited.
AnalystsBULLISH

5 of 6 rate it Buy or better.
TrendDOWNTREND

14% below its 50-day average. New closing low $2.25 on Oct 23.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
VANGUARD CAPITAL MANAGEMENT LLC	DOUBLED	356,448	$1.5M
BlackRock, Inc.	DOUBLED	61,353	$249.7K
VANGUARD FIDUCIARY TRUST CO	DOUBLED	50,765	$206.6K
UBS Group AG	ADD	5,643	$23.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

6 analysts

Buy 83% rate it Buy or better

Strong Buy2Buy3Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access

Recent actions

Date	Firm	Action	Rating
Oct 23, 2026	D. Boral Capital INITIATE	INITIATE	Buy
Oct 5, 2026	Craig-Hallum INITIATE	INITIATE	Buy

Catalysts

Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.

Upcoming

Nov 9, 2026

Earnings date

QTI Q3 2026 Earnings Scheduled — 2026-11-09

Recent

Aug 12, 2026

Earnings date

QTI Q2 2026 Earnings Scheduled — 2026-08-12

Aug 5, 2026

Earnings date

QTI Q2 2026 Earnings Scheduled — 2026-08-05

May 13, 2026

Earnings date

QTI Q1 2026 Earnings Scheduled — 2026-05-13

May 11, 2026

Earnings date

QTI Q1 2026 Earnings Scheduled — 2026-05-11

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Aug 28, 2026	Dinu Raluca Chief Executive Officer	AWARD	484,221 sh
Aug 4, 2026	TIMM BRYAN Director	AWARD	9,000 sh
Mar 20, 2026	GREENE JAMES S Director	AWARD	3,500 sh
Mar 20, 2026	Dinu Raluca Chief Executive Officer	AWARD	16,000 sh
Mar 20, 2026	DICKSON DANIEL H Director	AWARD	3,500 sh
Mar 20, 2026	Katz Avi S Chairman	AWARD	3,500 sh
Mar 20, 2026	Weiner Zeev Director	AWARD	3,500 sh
Mar 20, 2026	Dinu Raluca Chief Executive Officer	AWARD	500,000 sh

Earnings setup

Estimates

Nov 9

reports in 13 days

Revision history: 🔒 Fresh data, subscribers only

Period	EPS est.	Range	30D rev.	Revenue
Current Q	🔒 Fresh data, subscribers only
Next Q	🔒 Fresh data, subscribers only
Current FY	🔒 Fresh data, subscribers only
Next FY	🔒 Fresh data, subscribers only